Insight Molecular Diagnostics Inc. (IMDX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear

Insight Molecular Diagnos...

NASDAQ: IMDX · Real-Time Price · USD
3.33
0.07 (2.15%)
At close: Sep 26, 2025, 3:55 PM
3.33
0.00%
After-hours: Sep 26, 2025, 04:10 PM EDT

Insight Molecular Diagnostics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.51 -0.69 -0.49 -3.01
PEG Ratio
-0.02 0.01 0.06 -0.05
PS Ratio
16.54 12.73 37.13 87.79
PB Ratio
-2.53 0.75 1.04 2.96
P/FCF Ratio
-1.47 -0.81 -0.71 -5.05
P/OCF Ratio
-1.5 -0.82 -0.78 -5.37
OCF/S Ratio
-11.01 -15.52 -47.57 -16.35
Debt / Equity Ratio
-0.3 0.11 0.10 0.09
Quick Ratio
1.56 1.49 1.93 2.75
Current Ratio
1.62 1.49 2.11 2.77
Asset Turnover
0.05 0.02 0.01 0.01
Interest Coverage
-726.68 -483.38 -216.83 -113.75
Return on Equity
4.94 -1.09 -2.13 -0.98
Return on Assets
-1.73 -0.37 -0.73 -0.4
Return on Invested Capital
-2.1 -0.36 -0.2 -0.13
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.39 0.33 0.08 0.09
Net Profit Margin
-32.25 -18.48 -76.1 -29.16
Pretax Profit Margin
-32.25 -16.54 -19.43 -24.05
Operating Profit Margin
-32.45 -16.72 -18.79 -10.82
FCF Margin
-11.29 -15.71 -52.1 -17.37
EBITDA Margin
-31.37 -15.38 -13.9 -22.05